Search for content, post, videos
Advertisement

Genmab to acquire ProfoundBio

The two companies have entered into a definitive agreement for Genmab to acquire ProfoundBio in an all-cash transaction. Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at closing. Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at closing. “The propo
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.